Dr. Reddy’s Laboratories has launched the Sputnik V Covid vaccine in India with the first dose of the Russian vaccine administered today in Hyderabad.

The soft launch of the Russian coronavirus vaccine follows the landing of the first batch of its imported doses in India earlier this month and the subsequent regulatory clearance from the Central Drugs Laboratory in Kasauli.

Dr. Reddy’s Laboratories said that further consignments of imported doses are anticipated to land in the country over the upcoming months.

The company said that the supply of the human adenoviral vector platform-based Sputnik V vaccine will start from Indian manufacturing partners.

Currently, the imported doses of the Russian coronavirus vaccine are priced at INR 948 + 5% GST per dose. Dr. Reddy’s Laboratories said that there is scope for reducing the Covid vaccine price when local supply kicks off.

The Indian pharma giant said that it is closely working with its six manufacturing partners in the country to meet regulatory requirements for ensuring seamless and timely supply.

Furthermore, Dr. Reddy’s Laboratories will closely work with stakeholders in the Indian government and private sector for ensuring that the Sputnik V Covid vaccine has the widest possible reach as part of the country’s inoculation effort.

G V Prasad – Co-Chairman and Managing Director of Dr. Reddy’s Laboratories said: “With the rising cases in India, vaccination is our most effective tool in our battle against COVID-19. Contributing to the vaccination drive in India is our biggest priority right now to help Indians be healthy and safe.”

  Coronavirus, coronavirus vaccine, COVID-19, Dr. Reddy’s Laboratories, Dr. Reddy’s Labs, G V Prasad, Hyderabad, India, RDIF, Russia, Sputnik V vaccine